Ibopamine 2% eyedrops in the treatment of patients with ocular hypotony after vitreoretinal surgery for retinal detachment or uveitis; Results after six months of treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21285

Enrollment

Registered

2005-08-23

Start date

2004-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Long-term topical treatment with Ibopamine (2%) eye drops.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hypotony (0-5 mm Hg); 2. Stable eye pressure for at least 4 months; 3. No reaction of eye pressure to atropine and steroids; 4. Continued steroid treatment during past six months; 5. Status after vitreoretinal surgery or uveitis.

Exclusion criteria

Exclusion criteria: 1. Chronical heart failure; 2. Hypotony caused by other factors than surgery or uveitis; 3. Traction on corpus ciliare; 4. Cyclodialysis.

Design outcomes

Primary

Measure	Time frame
1. Ocular pressure; 2. Vision.	—

Secondary

Measure	Time frame
1. Position of silicone oil (after surgery); 2. Patient’s comfort/pain 5 minutes after eye drops adminstration.	—

Contacts

Public ContactJ.C. Meurs, van

Oogziekenhuis Rotterdam, Schiedamsevest 180

vanMeurs@oogziekenhuis.nl+31 (0)10 4017777

Outcome results